LAVA Therapeutics N.V. ( LVTX) - Key Metrics
Stock symbol LVTX is outdated, potentially delisted? Maybe it is available on other exchange?
LVTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | ? | -$0.13 | $0.08 | $0.08 |
| 2024Q4 | $0.19 | -$0.15 | -$0.05 | -$0.05 |
| 2024Q3 | ? | -$0.46 | -$0.32 | -$0.32 |
| 2024Q2 | ? | -$0.31 | -$0.31 | -$0.31 |
| 2024Q1 | $0.26 | -$0.02 | -$0.04 | -$0.04 |
LVTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -2.45 |
| 2024Q4 | ? | -1.61 |
| 2024Q3 | ? | -0.91 |
| 2024Q2 | ? | -1.51 |
| 2024Q1 | ? | -40.82 |
LVTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q1 | 5.93% | ? |
| 2024Q4 | -5.50% | ? |
| 2024Q3 | -19.42% | ? |
| 2024Q2 | -16.72% | ? |
| 2024Q1 | -1.25% | ? |
LVTX
Price: $1.74
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.87 USD
P/E Ratio: -2
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 12191
Market Capitalization: 45.8 million